The major reason why the said letter has gained much attention from different quarters is that it was from the office of Dr. Terrence L. Boos who is the Section Chief of the Drug and Chemical Evaluation Section. The section is under the Office of Diversion Control in the DEA and this particular letter was written to the Executive Secretary of the Board of Pharmacy of Alabama who requested a control status update on delta-8 THC. This means the contents of the letter can easily be used to juxtapose the current stand of the DEA as it applies to substance control for delta-8 THC.
Ladies and gentlemen, we have a new contender for the most audacious cannabis caper of…
How much should an ounce of weed cost? As the U.S. cannabis market surges past…
Find the best high-potency hemp products of 2025. Leafly reviewed popular hemp products & chose…
A breakdown of the situation regarding hemp, cannabis, and THCA—courtesy of The Hemp Doctor. The…
Well, folks, it looks like Donald Trump might be the best thing to happen to…
In a policy memo that reeks of entitlement, the American Beverage Licensees (ABL) trade association…